AmeriPath is a leading provider of anatomic pathology, molecular diagnostics, and specialized laboratory services in the United States. The company offers comprehensive pathology services to physicians, hospitals, clinics, and other healthcare providers. Established in 1999, AmeriPath has grown to become one of the largest and most respected diagnostic services providers in the country.

The company's headquarters is located in Sunrise, Florida. AmeriPath offers a wide range of products and services to assist in the diagnosis and treatment of patients. Their core services include surgical pathology, cytology, hematopathology, and molecular diagnostics.

These services help identify diseases, assess their severity, and guide healthcare providers in making treatment decisions. Operating on a global scale, AmeriPath has several noteworthy subsidiaries, joint ventures, and partnerships. The company is a subsidiary of Quest Diagnostics, a leading provider of diagnostic information services.

AmeriPath has also entered into partnerships with various healthcare organizations to expand its reach and offer its services to more patients around the world. In terms of market position, AmeriPath is considered a prominent player in the field of pathology services. With its extensive network of laboratories and high-quality diagnostic services, the company has gained a strong reputation within the healthcare industry.

While specific sales figures are not publicly available, AmeriPath's position among competitors is notable due to its size, capabilities, and association with Quest Diagnostics. AmeriPath has significantly contributed to the advancement of anatomic pathology and molecular diagnostics. The company has continuously invested in technology and research to offer innovative solutions and improve patient outcomes.

Over the years, AmeriPath has achieved significant milestones, including expanding its service offerings, enhancing laboratory capabilities, and adopting cutting-edge technologies. As of the latest available information, AmeriPath continues to be an industry leader, providing critical diagnostic services to physicians and healthcare providers across the United States. The company remains committed to delivering accurate and timely pathology results to aid in patient care and treatment decisions